The U.S. Supreme Court on Monday gave Merck & Co. a new opportunity to avoid lawsuits accusing the company of failing to properly warn patients of debilitating thigh-bone fractures from taking its osteoporosis drug Fosamax, throwing out a lower court …
from News – Insurance Journal
没有评论:
发表评论